FibroGen, Inc. (KYNB)
NASDAQ · Healthcare
FibroGen, Inc. Balance Sheet 2020–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total Assets | 119.6M | 214.5M | 423.5M | 610.1M | 773.8M | 826.8M |
| Cash & Equivalents | 47.9M | 50.5M | 113.7M | 155.7M | 171.2M | 678.4M |
| Liabilities | ||||||
| Total Liabilities | 115.1M | 398.2M | 585.7M | 611.6M | 544.7M | 385.4M |
| Long-Term Debt | — | 73.1M | 138.5M | 79.6M | 88.8M | 26.2M |
| Equity | ||||||
| Shareholders' Equity | 4.5M | -183.6M | -162.2M | -1.5M | 229.1M | 441.4M |
FibroGen, Inc. Balance Sheet — FAQ
FibroGen, Inc. (KYNB) balance sheet over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see KYNB's balance sheet history?
The chart and table above show FibroGen, Inc.'s balance sheet by year and by quarter, including the growth rate.